Condition: Eosinophilic Esophagitis
Interventions: Drug: Budesonide effervescent 0.5mg tablet twice daily; Drug: Budesonide effervescent 1mg tablet twice daily; Drug: Placebo effervescent tablet twice daily
Sponsor: Dr. Falk Pharma GmbH
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days